幹細胞銀行市場規模、佔有率、成長分析、按來源、按服務類型、按應用、按地區 - 產業預測，2024-2031年

2022年全球幹細胞庫市場規模為91億美元，預計從2023年的98.5億美元成長到2031年的186.5億美元，在預測期內（2024-2031年）年複合成長率為18.30%。

由於冷凍保存和細胞庫製備過程的進步，全球幹細胞庫市場經歷快速成長。在單株抗體和高效能生物製藥的普及推動下，幹細胞療法的日益普及，大大推動了市場需求。基於幹細胞的療法，特別是造血移植的持續研究和開發，為神經退化性疾病疾病和心血管疾病的治療提供了有希望的機會。組織庫和生物庫在保存各種臨床應用的成體組織和幹細胞方面發揮著非常重要的作用，低溫冷凍可確保其長期生存能力。針對以前無法治療的疾病的IPS 細胞等再生醫學的開拓將進一步提振市場。此外，晚婚的趨勢增加了人們對臍帶血庫作為生物保險形式的興趣，顯著推動了市場成長。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 二手資料來源和主要資料來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 依細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 課題
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 監管環境
• 案例研究分析
• 技術分析
• 供應鏈分析
• 價值鏈分析
• PESTEL分析

幹細胞銀行市場：依來源分類

• 市場概況
• 胎盤幹細胞（PSCS）
• 脂肪組織源性幹細胞（ADSCS）
• 骨髓來源幹細胞（BMSCS）
• 人類胚胎幹細胞（HESCS）
• 牙髓幹細胞（DPSCS）
• 其他來源

幹細胞銀行市場：依服務類型

• 市場概況
• 樣品保存及保存
• 樣品分析
• 樣品加工
• 樣本採集和運輸

幹細胞銀行市場：依應用分類

• 市場概況
• 個性化銀行應用程式
• 研究用途
  • 疾病治療研究
  • 生命科學研究
  • 藥物發現
• 臨床應用
  • 造血系統疾病
  • 自體免疫疾病
  • 其他疾病

幹細胞銀行市場：依地區

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲（MEA）
  • 海灣合作理事會國家
  • 南非
  • 其他中東、非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• Cordlife（Singapore）
• Cryo-Cell International（US）
• LifeCell International（India）
• StemCyte（US）
• Global Cord Blood（Hong Kong）
• Smart Cells International（UK）
• Vita34（Germany）
• CryoHoldco（US）
• Cellerant Therapeutics, Inc.（US）
• StemCell Technologies Inc.（Canada）
• Regenexx（US）
• Athersys, Inc.（US）
• Mesoblast Limited（Australia）
• Cytori Therapeutics, Inc.（US）
• OrthoGenics（US）
• Panthera Biopartners（UK）
• Stemson Therapeutics（US）
• Lonza Group AG（Switzerland）
• Macopharma（France）
• Cure Cell（Turkey）
• LifeBankUSA（US）
• Biolife Plasma Services, LLC（US）
• NexImmune, Inc.（US）

Global Stem Cell Banking Market size was valued at USD 9.1 billion in 2022 and is poised to grow from USD 9.85 billion in 2023 to USD 18.65 billion by 2031, growing at a CAGR of 18.30% during the forecast period (2024-2031).

The global stem cell banking market is witnessing rapid growth driven by advancements in cryopreservation and cell bank preparation processes. The rising adoption of stem cell therapy, fueled by the popularity of monoclonal antibodies and efficient biopharmaceuticals, is significantly enhancing market demand. Continuous R&D in stem cell-based therapies, particularly for hematopoietic transplantation, offers promising opportunities for treating neurodegenerative and cardiovascular diseases. Tissue banks and biobanks play a pivotal role in storing adult tissues and stem cells for diverse clinical applications, while cryogenic freezing ensures their long-term viability. The development of regenerative medicine, such as IPS cells for previously untreatable conditions, further boosts the market. Additionally, the trend of late parenthood has heightened interest in umbilical cord blood banking as a form of biological insurance, significantly driving market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Stem Cell Banking market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Stem Cell Banking Market Segmental Analysis

Global Stem Cell Banking Market is segmented by Source, Service Type, Application, and region. Based on Source, the market is segmented into Placental Stem Cells (PSCS), Adipose Tissue-Derived Stem Cells (ADSCS), Bone Marrow-Derived Stem Cells (BMSCS), Human Embryo-Derived Stem Cells (HESCS), Dental Pulp-Derived Stem Cells (DPSCS), and Other Stem Cell Sources. Based on Service Type, the market is segmented into Sample Preservation and Storage, Sample Analysis, Sample Processing, and Sample Collection and Transportation. Based on Application, the market is segmented into Personalized Banking Applications, Research Applications, and Clinical Applications. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Stem Cell Banking Market

Our analysis reveals that the global stem cell banking market is experiencing a significant shift toward the use of adult stem cells, particularly those derived from bone marrow or adipose tissue. These stem cells are gaining traction due to their ethical acceptability and ease of accessibility compared to embryonic stem cells. Additionally, advancements in minimally invasive collection techniques, such as needle-based bone marrow extraction, are enhancing patient convenience and reducing discomfort. This progress is driving increased adoption and awareness of stem cell banking, as it provides a reliable and patient-friendly option for preserving valuable biological resources. Consequently, these developments are propelling the growth and popularity of the stem cell banking market worldwide.

Restraints in the Global Stem Cell Banking Market

The global stem cell banking market faces a significant restraint in the form of ever-evolving regulatory frameworks. Governments worldwide are enforcing stringent guidelines to ensure safety and uphold ethical standards in stem cell research and banking. However, navigating these intricate and frequently changing regulatory landscapes presents a considerable challenge for market players. The continuous evolution or unpredictability of regulations often disrupts operations and hinders market growth. Companies must invest substantial resources to stay compliant, adapting their practices to align with new requirements, which can strain financial and operational capacities. This regulatory uncertainty not only adds complexity but also discourages potential investments and innovation in the sector, thereby acting as a barrier to the market's overall expansion.

Market Trends of the Global Stem Cell Banking Market

The growing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular conditions is driving the demand for innovative treatment solutions globally. Stem cell therapies are emerging as a promising approach to treat and potentially cure these chronic illnesses, showcasing transformative potential in healthcare. As a result, there is a rising need for readily available stem cell sources, which is fueling the growth of stem cell banking services. By providing a reliable repository for stem cells, these banks are positioned to support advancements in regenerative medicine and personalized treatments, catering to the evolving needs of the healthcare industry. This trend underscores the critical role of stem cell banking in shaping the future of disease management and therapeutic innovation.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Regulatory Landscape
• Case Study Analysis
• Technology Analysis
• Supply Chain Analysis
• Value Chain Analysis
• PESTEL Analysis

Stem Cell Banking Market by Source

• Market Overview
• Placental Stem Cells (PSCS)
• Adipose Tissue-Derived Stem Cells (ADSCS)
• Bone Marrow-Derived Stem Cells (BMSCS)
• Human Embryo-Derived Stem Cells (HESCS)
• Dental Pulp-Derived Stem Cells (DPSCS)
• Other Stem Cell Sources

Stem Cell Banking Market by Service Type

• Market Overview
• Sample Preservation and Storage
• Sample Analysis
• Sample Processing
• Sample Collection and Transportation

Stem Cell Banking Market by Application

• Market Overview
• Personalized Banking Applications
• Research Applications
  • Disease Treatment Studies
  • Life Science Research
  • Drug Discovery
• Clinical Applications
  • Hematopoietic Disorders
  • Autoimmune Disorders
  • Other Diseases

Stem Cell Banking Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Cordlife (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cryo-Cell International (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeCell International (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• StemCyte (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Global Cord Blood (Hong Kong)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smart Cells International (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vita34 (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoHoldco (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellerant Therapeutics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• StemCell Technologies Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Regenexx (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Athersys, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mesoblast Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytori Therapeutics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OrthoGenics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Panthera Biopartners (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stemson Therapeutics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macopharma (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cure Cell (Turkey)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeBankUSA (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biolife Plasma Services, LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NexImmune, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments